Literature DB >> 7608107

Activation of prothrombin by factor Xa bound to the membrane surface of human umbilical vein endothelial cells: its catalytic efficiency is similar to that of prothrombinase complex on platelets.

T Sugo1, C Nakamikawa, S Tanabe, M Matsuda.   

Abstract

Upon incubation of human prothrombin with factor Xa bound to human umbilical vein endothelial cells (HUVEC) (0.5-0.6 fmol factor Xa/10(5) cells), three bonds at Arg273-Thr274, Arg286-Thr287, and Arg322-Ile323 were cleaved, yielding and releasing fragment 1-2 and a degraded form of alpha-thrombin, but not meizothrombin, into the fluid phase. The apparent Km for prothrombin and the Vmax were 0.25 +/- 0.07 microM and 210 +/- 40 fmol thrombin/min/10(5) cells, respectively. For the maximally bound factor Xa, the calculated catalytic efficiency (kcat = 6-7 s-1) was similar to those reported for the prothrombinase complex formed on the phospholipid vesicles and natural membrane surfaces. The prothrombin derivatives lacking the 10 gamma-carboxyglutamic acid (Gla) residues-containing region were not activated by the cell-bound factor Xa. The activation rate of prothrombins with Gla residues variously modified to gamma-methyleneglutamic acids was reduced in accordance with the number of modified residues. For the inhibition of prothrombin activation, intact fragment 1 was needed; the Gla-domain alone did not affect the reaction. Binding of monoclonal antibodies to the region of 1-48 or the kringle 1 region of prothrombin also interfered with the prothrombin activation. Prothrombin activation on the surface of HUVEC appeared to proceed via formation of a cellular prothrombinase complex composed of phospholipids of HUVEC membrane, endogenous factor Va, factor Xa, and prothrombin. The Gla-domain and kringle 1 regions are indispensable for the molecule to serve as an effective substrate for the cell-bound factor Xa.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608107     DOI: 10.1093/jb/117.2.244

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

1.  Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex.

Authors:  H Deguchi; H Takeya; E C Gabazza; J Nishioka; K Suzuki
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

2.  Antithrombotic and antiplatelet activities of small-molecule alkaloids from Scolopendra subspinipes mutilans.

Authors:  Wonhwa Lee; JungIn Lee; Roshan Kulkarni; Mi-Ae Kim; Jae Sam Hwang; MinKyun Na; Jong-Sup Bae
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

3.  Inhibitory effects of lysozyme on endothelial protein C receptor shedding in vitro and in vivo.

Authors:  Sae-Kwang Ku; Eun-Kyung Yoon; Hyun Gyu Lee; Min-Su Han; Taeho Lee; Jong-Sup Bae
Journal:  BMB Rep       Date:  2015-11       Impact factor: 4.778

4.  Inhibition of platelet aggregation and thrombosis by indole alkaloids isolated from the edible insect Protaetia brevitarsis seulensis (Kolbe).

Authors:  JungIn Lee; Wonhwa Lee; Mi-Ae Kim; Jae Sam Hwang; MinKyun Na; Jong-Sup Bae
Journal:  J Cell Mol Med       Date:  2016-12-20       Impact factor: 5.310

5.  Synthesis and Thrombin, Factor Xa and U46619 Inhibitory Effects of Non-Amidino and Amidino N²-Thiophenecarbonyl- and N²-Tosylanthranilamides.

Authors:  Soo Hyun Lee; Wonhwa Lee; ThiHa Nguyen; Il Soo Um; Jong-Sup Bae; Eunsook Ma
Journal:  Int J Mol Sci       Date:  2017-05-31       Impact factor: 5.923

6.  Antithrombotic properties of JJ1, a potent and novel thrombin inhibitor.

Authors:  Wonhwa Lee; Suyeon Lee; Joonhyeok Choi; Jun-Hyeong Park; Kyung-Min Kim; Jun-Goo Jee; Jong-Sup Bae
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

7.  Human endothelial cells and fibroblasts express and produce the coagulation proteins necessary for thrombin generation.

Authors:  Clay T Cohen; Nancy A Turner; Joel L Moake
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.379

8.  Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivo.

Authors:  Sae-Kwang Ku; Jong-Sup Bae
Journal:  BMB Rep       Date:  2014-07       Impact factor: 4.778

9.  Anticoagulant activities of piperlonguminine in vitro and in vivo.

Authors:  Wonhwa Lee; Hayoung Yoo; Sae-Kwang Ku; Jeong Ah Kim; Jong-Sup Bae
Journal:  BMB Rep       Date:  2013-10       Impact factor: 4.778

10.  Apixaban Enhances Vasodilatation Mediated by Protease-Activated Receptor 2 in Isolated Rat Arteries.

Authors:  Ambra Villari; Giovanni Giurdanella; Claudio Bucolo; Filippo Drago; Salvatore Salomone
Journal:  Front Pharmacol       Date:  2017-07-18       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.